Sonal Bhatia

Sonal Bhatia, MD, serves as an Executive & Founding Board Member at Blend, fostering collaboration among enterprise leaders since May 2024. With extensive experience at Pfizer since September 2007, roles include CMO & SVP of US Medical Affairs for Rare Disease, Immunology & Inflammation, and Vice President for North America Medical Lead in Rare Disease. Additionally, Sonal Bhatia contributes to Pratham USA and the American Heart Association as a board member. A former Vice President and Medical Director at Cline Davis & Mann, educational credentials include an MD from the Icahn School of Medicine at Mount Sinai and a Bachelor of Science from the University of Toronto, among other advanced medical degrees.